Time to first antimicrobial administration after onset of sepsis in critically ill children

Nicholas M Fusco1, Kristine A Parbuoni2, Jill A Morgan3

  • 1Department of Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, New York.

Insights

Antimicrobial administration for pediatric sepsis exceeded recommended times, impacting patient care. Improving treatment protocols is crucial for better outcomes in critically ill children.

Area of Science:

  • Pediatric Critical Care Medicine
  • Infectious Diseases
  • Clinical Pharmacy

Background:

  • Delayed antimicrobial administration in severe sepsis and septic shock correlates with reduced survival in adults.
  • Establishing optimal antimicrobial timing in pediatric populations is essential for improving patient outcomes.

Purpose of the Study:

  • To determine the time to first antimicrobial administration in critically ill children with sepsis.
  • To evaluate the appropriateness of antimicrobial regimens, microbiological testing, and fluid resuscitation.
  • To assess intensive care unit (ICU) and hospital length of stay, as well as mortality rates.

Main Methods:

  • Retrospective chart review of pediatric patients (≤18 years) diagnosed with sepsis.
  • Study period: January 1, 2011, to December 31, 2012.
  • Inclusion criteria: Admission to the pediatric intensive care unit (PICU) with sepsis diagnosis.

Main Results:

  • Median time to first antimicrobial administration was 2.7 hours.
  • Cultures obtained before antimicrobials in 91.7% of cases; 72.2% had repeat cultures within 48 hours.
  • Empiric antimicrobial regimens were appropriate in 91.7% of cases; common regimens included piperacillin/tazobactam plus vancomycin or ceftriaxone plus vancomycin.
  • Median PICU length of stay was approximately 5 days; median hospital length of stay was approximately 12 days.
  • Four deaths occurred during the study period.

Conclusions:

  • Time to first antimicrobial administration in pediatric sepsis patients exceeded international guideline recommendations.
  • Current treatment processes for pediatric severe sepsis and septic shock require modification to align with national guidelines.
  • Enhancing compliance with established guidelines is necessary to optimize care and improve outcomes for critically ill children.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
838
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to...
533
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
739
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
886
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
505